A business opportunity or dilemma? by Lau, Yeng Wai & Ng, Siew Imm
Update on the management of Peripheral Arterial Disease (PAD). 
 
ABSTRACT 
There has been much progress made in the management of peripheral arterial disease (PAD) 
in the past two decades. Progress in the understanding of the endothelial-platelet interaction 
during health and disease state have resulted in better antiplatelet drugs that can prevent 
platelet aggregation, activation and thrombosis during angioplasty and stenting. Collaborative 
effort by different international societies has resulted in a consensus guideline that 
recommends the modality of intervention in certain disease states. Progress in perioperative 
care has reduced the morbidity and mortality associated with peripheral vascular 
reconstruction surgery. Nevertheless, the advances in percutaneous peripheral intervention 
(PPI) have made a paradigm shift in the current management of patients. The procedure is 
safe and effective and is emerging as the first choice revascularization procedure. 
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